On ‐target sorafenib toxicity predicts improved survival in hepatocellular carcinoma: a multi‐centre, prospective study

ConclusionDevelopment of sorafenib‐related toxicity including diarrhoea, hypertension and hand‐foot syndrome is associated with prolonged overall survival in patients with advanced‐stage HCC on sorafenib.

Source: Alimentary Pharmacology and Therapeutics - March 1, 2017 Category: Drugs & Pharmacology Authors: J. Howell, D. J. Pinato, R. Ramaswami, D. Bettinger, T. Arizumi, C. Ferrari, C. Yen, A. Gibbin, M. E. Burlone, G. Guaschino, L. Sellers, J. Black, M. Pirisi, M. Kudo, R. Thimme, J. ‐W. Park, R. Sharma Tags: Original Article Source Type: research